• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人肝脏树突状细胞促进T细胞低反应性。

Human liver dendritic cells promote T cell hyporesponsiveness.

作者信息

Bamboat Zubin M, Stableford Jennifer A, Plitas George, Burt Bryan M, Nguyen Hoang M, Welles Alexander P, Gonen Mithat, Young James W, DeMatteo Ronald P

机构信息

Hepatopancreatobiliary Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10065, USA.

出版信息

J Immunol. 2009 Feb 15;182(4):1901-11. doi: 10.4049/jimmunol.0803404.

DOI:10.4049/jimmunol.0803404
PMID:19201843
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3254024/
Abstract

The liver is believed to promote tolerance, which may be beneficial due to its constant exposure to foreign Ags from the portal circulation. Although dendritic cells (DCs) are critical mediators of immune responses, little is known about human liver DCs. We compared freshly purified liver DCs from surgical specimens with autologous blood DCs. Liver and blood DCs were equally immature, but had distinct subset compositions. BDCA-1(+) DCs represented the most prevalent liver DC subset, whereas the majority of peripheral blood DCs were CD16(+). Upon TLR4 ligation, blood DCs secreted multiple proinflammatory cytokines, whereas liver DCs produced substantial amounts of IL-10. Liver DCs induced less proliferation of allogeneic T cells both in a primary MLR and after restimulation. Similarly, Ag-specific CD4(+) T cells were less responsive to restimulation when initially stimulated by autologous liver DCs rather than blood DCs. In addition, liver DCs generated more suppressive CD4(+)CD25(+)FoxP3(+) T regulatory cells and IL-4-producing Th2 cells via an IL-10-dependent mechanism. Our findings are critical to understanding hepatic immunity and demonstrate that human liver DCs promote immunologic hyporesponsiveness that may contribute to hepatic tolerance.

摘要

肝脏被认为可促进免疫耐受,鉴于其持续暴露于来自门静脉循环的外来抗原,这可能是有益的。尽管树突状细胞(DCs)是免疫反应的关键介质,但对人肝脏DCs却知之甚少。我们将手术标本中新鲜纯化的肝脏DCs与自体血液DCs进行了比较。肝脏和血液DCs同样未成熟,但具有不同的亚群组成。BDCA-1(+) DCs是最主要的肝脏DC亚群,而外周血DCs大多数为CD16(+)。经Toll样受体4(TLR4)连接后,血液DCs分泌多种促炎细胞因子,而肝脏DCs产生大量白细胞介素-10(IL-10)。在初次混合淋巴细胞反应(MLR)及再次刺激后,肝脏DCs诱导的同种异体T细胞增殖较少。同样,当抗原特异性CD4(+) T细胞最初由自体肝脏DCs而非血液DCs刺激时,对再次刺激的反应性较低。此外,肝脏DCs通过IL-10依赖机制产生更多抑制性CD4(+)CD25(+)FoxP3(+)调节性T细胞和产生IL-4的辅助性T2(Th2)细胞。我们这些发现对于理解肝脏免疫至关重要,并表明人肝脏DCs促进免疫低反应性,这可能有助于肝脏耐受。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b95/3254024/bad6de584632/nihms347029f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b95/3254024/9c3e89b454f0/nihms347029f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b95/3254024/63ccaa38a0c2/nihms347029f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b95/3254024/c8481af668af/nihms347029f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b95/3254024/73b30370be67/nihms347029f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b95/3254024/c5129b7daf49/nihms347029f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b95/3254024/965dd65b5ea3/nihms347029f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b95/3254024/78a700248798/nihms347029f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b95/3254024/bad6de584632/nihms347029f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b95/3254024/9c3e89b454f0/nihms347029f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b95/3254024/63ccaa38a0c2/nihms347029f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b95/3254024/c8481af668af/nihms347029f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b95/3254024/73b30370be67/nihms347029f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b95/3254024/c5129b7daf49/nihms347029f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b95/3254024/965dd65b5ea3/nihms347029f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b95/3254024/78a700248798/nihms347029f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b95/3254024/bad6de584632/nihms347029f8.jpg

相似文献

1
Human liver dendritic cells promote T cell hyporesponsiveness.人肝脏树突状细胞促进T细胞低反应性。
J Immunol. 2009 Feb 15;182(4):1901-11. doi: 10.4049/jimmunol.0803404.
2
Engineered Dendritic Cell-Directed Concurrent Activation of Multiple T cell Inhibitory Pathways Induces Robust Immune Tolerance.工程化树突状细胞定向同时激活多条 T 细胞抑制途径诱导强大的免疫耐受。
Sci Rep. 2019 Aug 19;9(1):12065. doi: 10.1038/s41598-019-48464-y.
3
The role of CD11c(+) hepatic dendritic cells in the induction of innate immune responses.CD11c(+)肝树突状细胞在先天免疫应答诱导中的作用。
Clin Exp Immunol. 2007 Aug;149(2):335-43. doi: 10.1111/j.1365-2249.2007.03419.x. Epub 2007 May 22.
4
Neutrophil elastase treated dendritic cells promote the generation of CD4(+)FOXP3(+) regulatory T cells in vitro.中性粒细胞弹性蛋白酶处理的树突状细胞促进体外 CD4(+)FOXP3(+)调节性 T 细胞的生成。
Cell Immunol. 2011;269(2):128-34. doi: 10.1016/j.cellimm.2011.03.013. Epub 2011 Mar 17.
5
Induction of FOXP3-expressing regulatory CD4pos T cells by human mature autologous dendritic cells.人成熟自体树突状细胞诱导表达FOXP3的调节性CD4阳性T细胞
Eur J Immunol. 2004 Mar;34(3):762-772. doi: 10.1002/eji.200324552.
6
Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.树突状细胞类型,即哺乳动物胸腺微环境中的辅助细胞。树突状神经-内分泌-免疫细胞网络中的抗原呈递。
In Vivo. 1997 Jul-Aug;11(4):351-70.
7
IL-12-impaired and IL-12-secreting dendritic cells produce IL-23 upon CD154 restimulation.IL-12功能受损的和分泌IL-12的树突状细胞在CD154再次刺激后产生IL-23。
J Immunol. 2008 May 15;180(10):6629-39. doi: 10.4049/jimmunol.180.10.6629.
8
Antigen presentation and immune regulatory capacity of immature and mature-enriched antigen presenting (dendritic) cells derived from human bone marrow.源自人骨髓的未成熟和成熟富集抗原呈递(树突状)细胞的抗原呈递及免疫调节能力
Hum Immunol. 2004 Feb;65(2):93-103. doi: 10.1016/j.humimm.2003.11.002.
9
Tolerogenic dendritic cells inhibit antiphospholipid syndrome derived effector/memory CD4⁺ T cell response to β2GPI.耐受性树突状细胞抑制抗磷脂综合征来源的效应/记忆 CD4⁺T 细胞对β2GPI 的反应。
Ann Rheum Dis. 2012 Jan;71(1):120-8. doi: 10.1136/annrheumdis-2011-200063. Epub 2011 Sep 12.
10
Generation of Aspergillus- and CMV- specific T-cell responses using autologous fast DC.使用自体快速树突状细胞产生针对曲霉和巨细胞病毒的特异性T细胞反应。
Cytotherapy. 2004;6(3):223-34. doi: 10.1080/14653240410006040.

引用本文的文献

1
Function of F-FDG PET/CT radiomics in the detection of checkpoint inhibitor-induced liver injury (CHILI).F-FDG PET/CT 影像组学在检测免疫检查点抑制剂诱导的肝损伤(CHILI)中的作用。
EJNMMI Rep. 2025 Aug 4;9(1):27. doi: 10.1186/s41824-025-00258-4.
2
Myeloid cells in chronic liver inflammation.慢性肝脏炎症中的髓样细胞。
Cell Mol Immunol. 2025 Jul 28. doi: 10.1038/s41423-025-01324-4.
3
Overview of dendritic cells subsets and their involvement in immune-related pathological disease.树突状细胞亚群概述及其在免疫相关病理疾病中的作用

本文引用的文献

1
Human dendritic cells and transplant outcome.人类树突状细胞与移植结果。
Transplantation. 2008 Jun 15;85(11):1513-22. doi: 10.1097/TP.0b013e318173a768.
2
Alarming dendritic cells for Th2 induction.用于诱导Th2的警报树突状细胞。
J Exp Med. 2008 Jan 21;205(1):13-7. doi: 10.1084/jem.20072665. Epub 2008 Jan 14.
3
Taking dendritic cells into medicine.将树突状细胞应用于医学。
Bioimpacts. 2025 Jan 29;15:30671. doi: 10.34172/bi.30671. eCollection 2025.
4
Research Progress on the Immune Function of Liver Sinusoidal Endothelial Cells in Sepsis.脓毒症中肝窦内皮细胞免疫功能的研究进展
Cells. 2025 Mar 4;14(5):373. doi: 10.3390/cells14050373.
5
Evaluation of Anti-Angiogenic Therapy Combined with Immunotherapy and Chemotherapy as a Strategy to Treat Locally Advanced and Metastatic Non-Small-Cell Lung Cancer.评估抗血管生成疗法联合免疫疗法和化疗作为治疗局部晚期和转移性非小细胞肺癌的策略
Cancers (Basel). 2024 Dec 17;16(24):4207. doi: 10.3390/cancers16244207.
6
Engineering dendritic cell biomimetic membrane as a delivery system for tumor targeted therapy.工程树突状细胞仿生膜作为肿瘤靶向治疗的递送系统。
J Nanobiotechnology. 2024 Oct 27;22(1):663. doi: 10.1186/s12951-024-02913-7.
7
The renaissance of oral tolerance: merging tradition and new insights.口服耐受的复兴:融合传统与新见解
Nat Rev Immunol. 2025 Jan;25(1):42-56. doi: 10.1038/s41577-024-01077-7. Epub 2024 Sep 6.
8
Locoregional therapies combined with immune checkpoint inhibitors for liver metastases.局部区域疗法联合免疫检查点抑制剂治疗肝转移瘤
Cancer Cell Int. 2024 Aug 31;24(1):302. doi: 10.1186/s12935-024-03484-1.
9
Hepatocellular carcinoma immune microenvironment and check point inhibitors-current status.肝细胞癌免疫微环境与检查点抑制剂——现状
World J Hepatol. 2024 Mar 27;16(3):353-365. doi: 10.4254/wjh.v16.i3.353.
10
Impact of perinatal administration of probiotics on immune cell composition in neonatal mice.围产期给予益生菌对新生小鼠免疫细胞组成的影响。
Pediatr Res. 2024 Dec;96(7):1645-1654. doi: 10.1038/s41390-024-03029-2. Epub 2024 Jan 26.
Nature. 2007 Sep 27;449(7161):419-26. doi: 10.1038/nature06175.
4
Tolerogenic dendritic cells and the quest for transplant tolerance.耐受性树突状细胞与移植耐受的探索
Nat Rev Immunol. 2007 Aug;7(8):610-21. doi: 10.1038/nri2132. Epub 2007 Jul 13.
5
Resolution of a chronic viral infection after interleukin-10 receptor blockade.白细胞介素-10受体阻断后慢性病毒感染的消退
J Exp Med. 2006 Oct 30;203(11):2461-72. doi: 10.1084/jem.20061462. Epub 2006 Oct 9.
6
Hepatitis C virus E2 and CD81 interaction may be associated with altered trafficking of dendritic cells in chronic hepatitis C.丙型肝炎病毒E2与CD81的相互作用可能与慢性丙型肝炎中树突状细胞的转运改变有关。
Hepatology. 2006 Oct;44(4):945-54. doi: 10.1002/hep.21350.
7
Cellular and molecular mechanisms of liver tolerance.肝脏耐受的细胞和分子机制。
Immunol Rev. 2006 Oct;213:101-18. doi: 10.1111/j.1600-065X.2006.00435.x.
8
Human 6-sulfo LacNAc-expressing dendritic cells are principal producers of early interleukin-12 and are controlled by erythrocytes.表达人6-磺酸乳糖胺的树突状细胞是早期白细胞介素-12的主要产生者,并受红细胞调控。
Immunity. 2006 Jun;24(6):767-777. doi: 10.1016/j.immuni.2006.03.020.
9
Dendritic cells in a mature age.成熟阶段的树突状细胞。
Nat Rev Immunol. 2006 Jun;6(6):476-83. doi: 10.1038/nri1845.
10
Induction of a homeostatic circuit in lung tissue by microbial compounds.微生物化合物在肺组织中诱导稳态回路。
Immunity. 2006 Apr;24(4):475-87. doi: 10.1016/j.immuni.2006.02.008.